Boya Bio finalizes transfer of Jiangxi Xinhe stake

Boya Bio-Pharmaceutical Group has announced the successful transfer of its 80% equity stake in Jiangxi Boya Xinhe Pharmaceutical Co., Ltd. to Fuzhou High-tech Zone Financial Investment Group. The transaction, conducted through a public listing at the Shanghai United Assets and Equity Exchange, concluded on July 8, 2025, with Fuzhou High-tech Zone Financial Investment Group emerging as the sole bidder and acquiring the stake for CNY 15,816.55 million. Fuzhou High-tech Zone Financial Investment Group, wholly-owned by Fuzhou High-tech Zone State-owned Assets Investment Group, reported total assets of CNY 637,903.49 million and net assets of CNY 234,024.00 million as of March 31, 2025. The company recorded a net profit of CNY 2,021.24 million for the first three months of 2025. The transaction is not a related party transaction and does not constitute a major asset restructuring.